Centre uses Enfusion to take everything but alpha out of the equation
In 2021, Enfusion’s single PMS, OEMS, and accounting platform, along with Managed Services, replaced multiple separate systems and functions (trade execution, portfolio accounting and reconciliation, and trade transmission and custodian connectivity), which has significantly improved operational efficiencies and has allowed Centre to concentrate on investment management.
Having a single platform allows Centre to generate orders live to the street via Enfusion’s OEMS. In combination with integrated data from Bloomberg, they benefit from a real-time and accurate view of the entire portfolio and can easily adjust order size based on a live intra-day NAV. The net result is better risk awareness and better pre- and post-trade compliance. Furthermore, daily cash inflows and outflows to the funds are reflected via a simple upload process and can be equitized or monetized easily in alignment with the respective fund strategies.
Enfusion also eliminated the need for bespoke integrations for Centre’s risk management platform with its portfolio accounting, and trading systems, as well as SWIFT connectivity to underlying custodians and administrators. “Sometimes even small changes to these systems by the vendor would be disruptive to our bespoke coding that integrated them causing time consuming remedies for breaks and failures. We’ve had a near complete elimination of mistakes and trade breaks since using Enfusion and have full confidence in positions integrity across the funds, each with different custodians and fund administrators,” Abate added.
Corporate action processing, trade affirmation, and trade break resolution. Centre no longer experiences trade settlement delays due to common reasons such as local foreign exchange fees and commission calculations, while having total confidence in the proper capture of stock splits, dividend withholding taxes across jurisdictions, etc. Centre now enjoys full transparency and accuracy of data and time savings that ultimately enable the team to focus on generating alpha and managing risk.
Front-to-back capabilities and the support of Enfusion’s Managed Services allows Centre to focus on its one ultimate priority—managing money and delivering top performance. Centre’s American Select Equity Fund (offered in US mutual fund form and offshore UCITS) ranked as the top-performing fund in Morningstar’s US large-blend category during the one-, three- and five-year periods for the year ended December 31, 2022.